{"DataElement":{"publicId":"12120008","version":"1","preferredName":"Prescription Medication Pharmaceutical Formulation Type","preferredDefinition":"A description of the prescribed medication pharmaceutical formulation.","longName":"PRSC_MED_FORM_TY","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"12120006","version":"1","preferredName":"Prescription Medication Pharmaceutical Formulation","preferredDefinition":"A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure._A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries","longName":"2634972v1.00:5205054v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2634972","version":"1","preferredName":"Prescription Medication","preferredDefinition":"A doctor's order for medicine or another intervention.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.","longName":"C28180:C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prescription","conceptCode":"C28180","definition":"A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6796C7-9CD9-09F6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5205054","version":"1","preferredName":"Pharmaceutical Formulation","preferredDefinition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","longName":"C42638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmaceutical Formulation","conceptCode":"C42638","definition":"The composition of a dosage form, including the characteristics of its raw materials and the operations required to process it.Formulation factors include chemical nature of the drug (ester, salt, complex, etc), drug solubility in water and organic solvents, particle size and surface area, type of dosage form (solution, suspension, capsule, tablet) and the excipients and processes used in the manufacturing of the drug delivery systems. The design of optimal drug delivery systems is thus an important part of providing an effective therapeutic.Official formulations for approved agents are presented in such books as the National Formulary and US Pharmacopeia. Whereas at one time, these were detailed and almost recipe-like, more recent entries may be limited to specifying the formula and imposing a standard limit for the active agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EFD7A53-7676-169F-E050-BB89AD432600","latestVersionIndicator":"Yes","beginDate":"2016-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-26","modifiedBy":"ONEDATA","dateModified":"2016-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEDA2D40-0F99-053B-E053-731AD00A6A71","latestVersionIndicator":"Yes","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2023-01-23","changeDescription":null,"administrativeNotes":"2023.1.23 Released per review. ak2022.12.2 Created for ticket request CADSR0001748. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"12120007","version":"1","preferredName":"Medication Type","preferredDefinition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product._Something distinguishable as an identifiable class based on common qualities.","longName":"12120007v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pills","valueDescription":null,"ValueMeaning":{"publicId":"2579108","version":"1","preferredName":"Pill Dosage Form","longName":"2579108","preferredDefinition":"A dose of medicine in the form of a small pellet.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0211-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEDA4593-BFCF-087A-E053-731AD00A7E94","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","deletedIndicator":"No"},{"value":"Solution","valueDescription":null,"ValueMeaning":{"publicId":"2579126","version":"1","preferredName":"Solution Dosage Form","longName":"2579126","preferredDefinition":"A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solution Dosage Form","conceptCode":"C42986","definition":"A clear, homogeneous liquid composed of one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0223-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEDA4593-BFD0-087A-E053-731AD00A7E94","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","deletedIndicator":"No"},{"value":"IV","valueDescription":null,"ValueMeaning":{"publicId":"5335410","version":"1","preferredName":"Intravenous Route of Administration","longName":"5335410","preferredDefinition":"Administration within or into a vein or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36E51D41-9FEF-74F7-E050-BB89AD4334C4","latestVersionIndicator":"Yes","beginDate":"2016-07-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-05","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEDA4593-BFD1-087A-E053-731AD00A7E94","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","deletedIndicator":"No"},{"value":"None","valueDescription":null,"ValueMeaning":{"publicId":"6149013","version":"1","preferredName":"None","longName":"6149013v1.00","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68547E1A-4C9A-6A4E-E053-F662850A8A33","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"NELSONA","dateCreated":"2018-03-26","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EEDA4593-BFD2-087A-E053-731AD00A7E94","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2022-12-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7850269","version":"1","preferredName":"Medication Type","preferredDefinition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:Something distinguishable as an identifiable class based on common qualities.","longName":"C459:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B86414-4068-54F8-E053-4EBD850A148D","latestVersionIndicator":"Yes","beginDate":"2021-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-09","modifiedBy":"ONEDATA","dateModified":"2021-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEDA3C7B-C886-0793-E053-731AD00A94E5","latestVersionIndicator":"Yes","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2023-01-23","changeDescription":null,"administrativeNotes":"2023.1.23 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the prescribed medication pharmaceutical formulation?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Formulation(s) of levocarnitine prescribed:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEDA604B-CC75-0E97-E053-731AD00A1A10","latestVersionIndicator":"Yes","beginDate":"2022-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-12-02","modifiedBy":"KUMMEROA","dateModified":"2023-01-23","changeDescription":null,"administrativeNotes":"2023.1.23 Released per review. ak2022.12.2 Created for ticket request CADSR0001748. ak","unresolvedIssues":null,"deletedIndicator":"No"}}